extra spectrum. Instead, it needs more customers and higher margins. Deal of the day Qiagen, of Germany, a genetic testing specialist, has snapped up DxS, a British rival, to expand its cancer diagnostics business. It has paid $95 million (£58 million)...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to In the know: Deutsche Telekom ... Qiagen
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account